• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Seasonal variability of severe asthma exacerbations and clinical benefit from lebrikizumab.

作者信息

Staton Tracy L, Arron Joseph R, Olsson Julie, Holweg Cécile T J, Matthews John G, Choy David F

机构信息

Genentech, Inc, South San Francisco, Calif.

Genentech, Inc, South San Francisco, Calif.

出版信息

J Allergy Clin Immunol. 2017 May;139(5):1682-1684.e3. doi: 10.1016/j.jaci.2017.01.028. Epub 2017 Feb 24.

DOI:10.1016/j.jaci.2017.01.028
PMID:28238745
Abstract
摘要

相似文献

1
Seasonal variability of severe asthma exacerbations and clinical benefit from lebrikizumab.重度哮喘急性加重的季节性变异性及来瑞组单抗的临床获益
J Allergy Clin Immunol. 2017 May;139(5):1682-1684.e3. doi: 10.1016/j.jaci.2017.01.028. Epub 2017 Feb 24.
2
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials.Lebrikizumab 在未得到控制的哮喘患者中的疗效和安全性（LAVOLTA I 和 LAVOLTA II）：复制，III 期，随机，双盲，安慰剂对照试验。
Lancet Respir Med. 2016 Oct;4(10):781-796. doi: 10.1016/S2213-2600(16)30265-X. Epub 2016 Sep 5.
3
Anti-interleukin 5 Therapy for Eosinophilic Asthma: a Meta-analysis of Randomized Clinical Trials.抗白细胞介素 5 治疗嗜酸性粒细胞性哮喘：随机临床试验的荟萃分析。
Clin Rev Allergy Immunol. 2018 Apr;54(2):318-330. doi: 10.1007/s12016-016-8588-x.
4
Understanding the September asthma epidemic.了解9月哮喘流行情况。
J Allergy Clin Immunol. 2007 Sep;120(3):526-9. doi: 10.1016/j.jaci.2007.05.047. Epub 2007 Jul 20.
5
The influence of asthma control on the severity of virus-induced asthma exacerbations.哮喘控制对病毒诱发的哮喘急性加重严重程度的影响。
J Allergy Clin Immunol. 2015 Aug;136(2):497-500.e3. doi: 10.1016/j.jaci.2015.01.028. Epub 2015 Mar 13.
6
Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: A randomized controlled study.TLR3 阻断在鼻病毒诱导的实验性哮喘加重中的作用：一项随机对照研究。
J Allergy Clin Immunol. 2018 Apr;141(4):1220-1230. doi: 10.1016/j.jaci.2017.06.027. Epub 2017 Jul 20.
7
Seasonal variability of exacerbations of severe, uncontrolled eosinophilic asthma and clinical benefits of benralizumab.重度、未控制的嗜酸性粒细胞性哮喘加重的季节性变异性及贝那利珠单抗的临床获益
Allergy Asthma Proc. 2018 Sep 4;39(5):345-349. doi: 10.2500/aap.2018.39.4162. Epub 2018 Aug 4.
8
Meta-analysis of randomized controlled trials for the efficacy and safety of anti-interleukin-13 therapy with lebrikizumab in patients with uncontrolled asthma.在未控制哮喘患者中使用lebrikizumab进行抗白细胞介素-13治疗的疗效和安全性的随机对照试验的荟萃分析。
Allergy Asthma Proc. 2018 Sep 1;39(5):332-337. doi: 10.2500/aap.2018.39.4149.
9
Update on immunogenicity in severe asthma: Experience with mepolizumab.重度哮喘免疫原性的最新进展：美泊利单抗的应用经验
J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2469-2475.e1. doi: 10.1016/j.jaip.2019.03.042. Epub 2019 Apr 5.
10
Epidemiology of asthma exacerbations.哮喘急性加重的流行病学
J Allergy Clin Immunol. 2008 Oct;122(4):662-668. doi: 10.1016/j.jaci.2008.08.003.

引用本文的文献

1
Incidence and predictors of asthma exacerbations in middle-aged and older adults: the Rotterdam Study.中老年人群哮喘急性加重的发病率及预测因素：鹿特丹研究
ERJ Open Res. 2021 Jul 12;7(3). doi: 10.1183/23120541.00126-2021. eCollection 2021 Jul.
2
A Comprehensive Analysis of the Stability of Blood Eosinophil Levels.血液嗜酸性粒细胞水平稳定性的综合分析。
Ann Am Thorac Soc. 2021 Dec;18(12):1978-1987. doi: 10.1513/AnnalsATS.202010-1249OC.
3
Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b Study.
特泽佩umab可减少重度未控制哮喘患者全年的病情加重：PATHWAY 2b期研究的事后分析
J Asthma Allergy. 2021 Jan 11;14:1-11. doi: 10.2147/JAA.S286036. eCollection 2021.
4
INEXAS: A Phase 2 Randomized Trial of On-demand Inhaled Interferon Beta-1a in Severe Asthmatics.INEXAS：按需吸入重组人干扰素β-1a 在重度哮喘患者中的 2 期随机试验。
Clin Exp Allergy. 2021 Feb;51(2):273-283. doi: 10.1111/cea.13765. Epub 2020 Nov 3.
5
Real-World Effectiveness of Mepolizumab in Patients with Severe Asthma: An Examination of Exacerbations and Costs.美泊利珠单抗治疗重度哮喘患者的真实世界有效性：对病情加重情况和成本的考察
J Asthma Allergy. 2020 Jan 29;13:77-87. doi: 10.2147/JAA.S236609. eCollection 2020.
6
Seasonal variability of lung function and Asthma Quality of Life Questionnaire Scores in adults with uncontrolled asthma.成人哮喘控制不佳者肺功能和哮喘生活质量问卷评分的季节性变化。
BMJ Open Respir Res. 2019 Nov 11;6(1):e000406. doi: 10.1136/bmjresp-2019-000406. eCollection 2019.